Cotreatment with darbepoetin and granulocyte colony-stimulating factor is efficient to recruit proangiogenic cell populations in patients with acute myocardial infarction

Cell Transplantation

Volumn 21, Issue 5, 2012, Pages 1055-1061

  Kang, Hyun Jae ^a   Yoon, Eun Jung ^a   Lee, Eun Ju ^a   Kim, Min Kyung ^a   Suh, Jung Won ^b   Park, Kyung Woo ^a   Lee, Hae Young ^a   Park, Kyoung Un ^b   Cho, Young Seok ^b   Koo, Bon Kwon ^a   Chae, In Ho ^b   Choi, Dong Ju ^b   Han, Kyu Sup ^a   Kim, Hyo Soo ^a   Park, Young Bae ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Acute myocardial infarction (AMI); Erythropoietin; Granulocyte colony stimulating factor (G CSF); Progenitor cell; Stem cell

Indexed keywords

ANGIOPOIETIN RECEPTOR; C REACTIVE PROTEIN; CADHERIN; CD3 ANTIGEN; CD31 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CREATINE KINASE MB; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; VASCULAR ENDOTHELIAL CADHERIN;

ACUTE HEART INFARCTION; ADULT; APHERESIS; ARTICLE; BONE PAIN; CARDIAC PATIENT; CD34 SELECTION; CELL COUNT; CELL POPULATION; CHEMOTAXIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FEVER; FLOW CYTOMETRY; HEADACHE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; INFLAMMATORY CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MONOTHERAPY; MYALGIA; PARESTHESIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; THROMBOCYTE COUNT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; CORONARY ANGIOGRAPHY; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; ERYTHROPOIETIN; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATINICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECEPTOR, TIE-2; STEM CELLS; T-LYMPHOCYTES;

EID: 84862561588     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X627499     Document Type: Article

References (25)

1. Bouchentouf, M.; Paradis, P.; Forner, K. A.; Cuerquis, J.; Boivin, M. N.; Zheng, J.; Boulassel, M. R.; Routy, J. P.; Schiffrin, E. L.; Galipeau, J. Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction. Cell Transplant. 19(4):369-386; 2010
2. Brunner, S.; Winogradow, J.; Huber, B. C.; Zaruba, M. M.; Fischer, R.; David, R.; Assmann, G.; Herbach, N.; Wanke, R.; Mueller-Hoecker, J.; Franz, W. M. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis. FASEB J. 23(2):351-361; 2009.
3. Chang, S. A.; Kang, H. J.; Lee, H. Y.; Kim, K. H.; Hur, J.; Han, K. S.; Park, Y. B.; Kim, H. S. Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion. Heart 95(16):1326-1330; 2009.
4. Erbs, S.; Linke, A.; Adams, V.; Lenk, K.; Thiele, H.; Diederich, K. W.; Emmrich, F.; Kluge, R.; Kendziorra, K.; Sabri, O.; Schuler, G.; Hambrecht, R. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: First randomized and placebo-controlled study. Circ. Res. 97:756-762; 2005.
5. Heeschen, C.; Aicher, A.; Lehmann, R.; Fichtlscherer, S.; Vasa, M.; Urbich, C.; Mildner-Rihm, C.; Martin, H.; Zeiher, A. M.; Dimmeler, S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102:1340-1346; 2003.
6. Honold, J.; Lehmann, R.; Heeschen, C.; Walter, D. H.; Assmus, B.; Sasaki, K.; Martin, H.; Haendeler, J.; Zeiher, A. M.; Dimmeler, S. Effects of granulocyte colony stimulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease. Arterioscler. Thromb. Vasc. Biol. 26(10):2238-2243; 2006.
7. Hur, J.; Yang, H. M.; Yoon, C. H.; Lee, C. S.; Park, K. W.; Kim, J. H.; Kim, T. Y.; Kim, J. Y.; Kang, H. J.; Chae, I. H.; Oh, B. H.; Park, Y. B.; Kim, H. S. Identification of a novel role of T cells in postnatal vasculogenesis: Characterization of endothelial progenitor cell colonies. Circulation 116(15):1671-1682; 2007.
8. + hemangiocytes. Nat. Med. 12(5): 557-567; 2006.
9. Kang, H. J.; Kim, H. S.; Zhang, S. Y.; Park, K. W.; Cho, H. J.; Koo, B. K.; Kim, Y. J.; Lee, D. S.; Sohn, D. W.; Han, K. S.; Oh, B. H.; Lee, M. M.; Park, Y. B. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 363:751-756; 2004.
10. Kang, H. J.; Lee, H. Y.; Na, S. H.; Chang, S. A.; Park, K. W.; Kim, H. K.; Kim, S. Y.; Chang, H. J.; Lee, W.; Kang, W. J.; Koo, B. K.; Kim, Y. J.; Lee, D. S.; Sohn, D. W.; Han, K. S.; Oh, B. H.; Park, Y. B.; Kim, H. S. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: The MAGIC cell-3-DES randomized controlled trial. Circulation 114:I145-151; 2006.
11. Kim, M. S.; Lee, C. S.; Hur, J.; Cho, H. J.; Jun, S. I.; Kim, T. Y.; Lee, S. W.; Suh, J. W.; Park, K. W.; Lee, H. Y.; Kang, H. J.; Lee, D. S.; Koh, G. Y.; Nakagami, H.; Morishita, R.; Park, Y. B.; Kim, H. S. Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2/Ets-1 pathway. Circulation 120(22):2240-2250; 2009.
12. Lipinski, M. J.; Biondi-Zoccai, G. G.; Abbate, A.; Khianey, R.; Sheiban, I.; Bartunek, J.; Vanderheyden, M.; Kim, H. S.; Kang, H. J.; Strauer, B. E.; Vetrovec, G. W. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction. J. Am. Coll. Cardiol. 50:1761-1767; 2007.
13. Lipsic, E.; van der Meer, P.; Voors, A. A.; Westenbrink, B. D.; van den Heuvel, A. F.; de Boer, H. C.; van Zonneveld, A. J.; Schoemaker, R. G.; van Gilst, W. H.; Zijlstra, F.; van Veldhuisen, D. J. A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: A randomized feasibility and safety study. Cardiovasc. Drugs Ther. 20:135-141; 2006.
14. Liu, S. P.; Lee, S. D.; Lee, H. T.; Liu, D. D.; Wang, H. J.; Liu, R. S.; Lin, S. Z.; Shyu, W. C. Granulocyte colonystimulating factor activating HIF-1alpha acts synergistically with erythropoietin to promote tissue plasticity. PLoS One 5(4):e10093; 2010.
15. Maiese, K.; Li, F.; Chong, Z. Z. New avenues of exploration for erythropoietin. JAMA 293(1):90-95; 2005.
16. Moriyama, M. T.; Tanaka, T.; Morita, N.; Ishii, T.; Chikazawa, I.; Suga, K.; Miyazawa, K.; Suzuki, K. Renal protective effects of erythropoietin on ischemic reperfusion injury. Cell Transplant. 19(6):713-721; 2010.
17. Suh, J. W.; Chung, W. Y.; Kim, Y. S.; Kim, K. I.; Jeon, E. J.; Cho, Y. S.; Youn, T. J.; Chae, I. H.; Kim, C. H.; Choi, D. J. The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention. Int. J. Cardiol. 149(2):216-220; 2011.
18. Tang, Y. D.; Hasan, F.; Giordano, F. J.; Pfau, S.; Rinder, H. M.; Katz, S. D. Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: Results of a double-blind, placebo-controlled, randomized trial. Am. Heart J. 158(6):941-947; 2009.
19. Ueda, K.; Takano, H.; Niitsuma, Y.; Hasegawa, H.; Uchiyama, R.; Oka, T.; Miyazaki, M.; Nakaya, H.; Komuro, I. Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice. J. Clin. Invest. 120(6):2016-2029; 2010.
20. Valgimigli, M.; Rigolin, G. M.; Cittanti, C.; Malagutti, P.; Curello, S.; Percoco, G.; Bugli, A. M.; Della Porta, M.; Bragotti, L. Z.; Ansani, L.; Mauro, E.; Lanfranchi, A.; Giganti, M.; Feggi, L.; Castoldi, G.; Ferrari, R. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: Clinical and angiographic safety profile. Eur. Heart J. 26:1838-1845; 2005.
21. van der Meer, P.; Lipsic, E.; Henning, R. H.; Boddeus, K.; van der Velden, J.; Voors, A. A.; van Veldhuisen, D. J.; van Gilst, W. H.; Schoemaker, R. G. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J. Am. Coll. Cardiol. 46(1):125-133; 2005.
22. Wang, L.; Chopp, M.; Teng, H.; Bolz, M.; Francisco, M. A.; Aluigi, D. M.; Li, W. X.; Zhang, R. L.; Chrsitensen, S.; Sager, T. N.; Szalad, A.; Zhang, Z. G. Tumor necrosis factor alpha primes cerebral endothelial cells for erythropoietin-induced angiogenesis. J. Cereb. Blood Flow Metab. 31(2):640-647; 2011.
23. Westenbrink, B. D.; Lipsic, E.; van der Meer, P.; van der Harst, P.; Oeseburg, H.; Du Marchie Sarvaas, G. J.; Koster, J.; Voors, A. A.; van Veldhuisen, D. J.; van Gilst, W. H.; Schoemaker, R. G. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur. Heart J. 28:2018-2027; 2007.
24. Youn, S. W.; Lee, S. W.; Lee, J.; Jeong, H. K.; Suh, J. W.; Yoon, C. H.; Kang, H. J.; Kim, H. Z.; Koh, G. Y.; Oh, B. H.; Park, Y. B.; Kim, H. S. COMP-Ang1 stimulates HIF-1{alpha}-mediated SDF-1 overexpression and recovers ischemic injury through BM-derived progenitor cell recruitment. Blood 117(16):4376-4386; 2011.
25. Zhang, D.; Zhang, F.; Zhang, Y.; Gao, X.; Li, C.; Yang, N.; Cao, K. Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair. Transpl. Int. 20(2):174-183; 2007.